Is RANKL a potential molecular target in osteoarthritis?

导出 LinkOut

翻译打印收藏纠错

第一作者： Dzenita,Muratovic

第一单位： Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia; Biomedical Orthopaedic Research Group, Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia. Electronic address: dzenita.muratovic@adelaide.edu.au.

作者： Dzenita,Muratovic ^[1] ; Gerald J,Atkins ^[2] ; David M,Findlay ^[3]

作者单位： Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia; Biomedical Orthopaedic Research Group, Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia. Electronic address: dzenita.muratovic@adelaide.edu.au. ^[1] Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia; Biomedical Orthopaedic Research Group, Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia. Electronic address: gerald.atkins@adelaide.edu.au. ^[2] Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia. Electronic address: david.findlay@adelaide.edu.au. ^[3]

关键词 Bone remodelling OPG/RANK/RANKL Osteoarthritis

主题词人类(Humans);软骨, 关节(Cartilage, Articular);细胞因子类(Cytokines);配体(Ligands);骨关节炎(Osteoarthritis);骨保护素(Osteoprotegerin);RANK配体(RANK Ligand)

DOI 10.1016/j.joca.2023.10.010

PMID 38160744

发布时间 2024-05-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交